Case Study: Psylo accelerates psychedelic drug discovery with CDD Vault

PSYLO evaluates 100 million compounds with CDD Vault

Psylo, a psychedelic-inspired drug discovery company, faced the challenge of managing rapidly growing datasets from its computational and experimental programs. As a virtual company collaborating with multiple CROs, it needed a secure, centralized platform to handle compound libraries, SAR data, and screening results, moving away from inefficient and insecure manual methods like spreadsheets. They implemented CDD Vault's registration system and ELN from Collaborative Drug Discovery to address this.

The solution provided by CDD Vault gave Psylo a single, secure source of truth for all its data, enabling efficient management and comparison of large datasets, including over 100 million computationally evaluated compounds. This resulted in improved oversight of SAR trends, streamlined collaboration with external partners, and a scalable foundation for research, patents, and fundraising. The CDD Vault platform proved invaluable for future-proofing Psylo's R&D program and supporting the development of its AI-based optimization framework.

PSYLO